Literature DB >> 26823916

Clinical significance and prognostic value of Nek2 protein expression in colon cancer.

Lei Lu1, Xiaofeng Zhai1, Ronghua Yuan1.   

Abstract

OBJECTIVE: To determine the expression of NIMA-related kinase NEK2 and evaluate its clinical value in colon cancer.
METHOD: Sixty specimens of colon cancer, 30 specimens of paracancerous colon tissues and 10 specimens of normal colon tissues conventionally resected in surgery at the Second Affiliated Hospital of Nantong University from February 2006 to February 2014 were collected. These tissues were detected for the expression of Nek2 using Western Blot and immunohistochemical staining. The relationship between Nek2 protein expression and the clinicopathology and prognosis of colon tissues was discussed.
RESULTS: The expression level and positive expression rate of Nek2 protein in the colon cancer were obviously higher than that in the paracancerous tissues and normal colon tissues. They were also significantly higher in the paracancerous tissues than in the normal tissues (P<0.05). Statistical analysis revealed that Nek2 protein expression was not obviously correlated with gender, age and tumor size, but obviously correlated with degree of differentiation (P=0.008), TNM staging (P=0.000), lymph node metastasis (P=0.022) and tumor invasion (P=0.011). With the plotting of Kaplan-Meier survival curve, it could be seen that Nek2 protein expression was not significantly correlated with survival (P=0.0048). High Nek2 protein expression may be an independent risk factor for colon cancer (HR=0.227, 95% CI 0.101-0.510).
CONCLUSION: High Nek2 protein expression reflects the malignant behavior of colon cancer. Playing important roles in the occurrence of colon cancer, Nek2 protein expression has diagnostic and prognostic value in colon cancer.

Entities:  

Keywords:  Colon cancer; Nek2; expression; prognosis

Mesh:

Substances:

Year:  2015        PMID: 26823916      PMCID: PMC4713702     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  19 in total

1.  Progress in the adjuvant treatment of colon cancer: has it influenced clinical practice?

Authors:  Eric Van Cutsem; Frederico Costa
Journal:  JAMA       Date:  2005-12-07       Impact factor: 56.272

2.  A centrosomal function for the human Nek2 protein kinase, a member of the NIMA family of cell cycle regulators.

Authors:  A M Fry; P Meraldi; E A Nigg
Journal:  EMBO J       Date:  1998-01-15       Impact factor: 11.598

3.  Nek2 as an effective target for inhibition of tumorigenic growth and peritoneal dissemination of cholangiocarcinoma.

Authors:  Toshio Kokuryo; Takeshi Senga; Yukihiro Yokoyama; Masato Nagino; Yuji Nimura; Michinari Hamaguchi
Journal:  Cancer Res       Date:  2007-10-15       Impact factor: 12.701

4.  Increased expression and nuclear localization of the centrosomal kinase Nek2 in human testicular seminomas.

Authors:  Federica Barbagallo; Maria P Paronetto; Renato Franco; Paolo Chieffi; Susanna Dolci; Andrew M Fry; Raffaele Geremia; Claudio Sette
Journal:  J Pathol       Date:  2009-02       Impact factor: 7.996

5.  A mammalian dual specificity protein kinase, Nek1, is related to the NIMA cell cycle regulator and highly expressed in meiotic germ cells.

Authors:  K Letwin; L Mizzen; B Motro; Y Ben-David; A Bernstein; T Pawson
Journal:  EMBO J       Date:  1992-10       Impact factor: 11.598

Review 6.  Nek2 kinase in chromosome instability and cancer.

Authors:  Daniel G Hayward; Andrew M Fry
Journal:  Cancer Lett       Date:  2005-08-03       Impact factor: 8.679

7.  Expression of glioma-associated oncogene homolog 1 is associated with invasion and postoperative liver metastasis in colon cancer.

Authors:  Yin-lu Ding; Yong Zhou; Lei Xiang; Zhi-peng Ji; Zhou-hong Luo
Journal:  Int J Med Sci       Date:  2012-06-21       Impact factor: 3.738

8.  The NIMA-related kinase 2, Nek2, is expressed in specific stages of the meiotic cell cycle and associates with meiotic chromosomes.

Authors:  K Rhee; D J Wolgemuth
Journal:  Development       Date:  1997-06       Impact factor: 6.868

9.  Genomic alterations in primary gastric adenocarcinomas correlate with clinicopathological characteristics and survival.

Authors:  Marjan M Weiss; Ernst J Kuipers; Cindy Postma; Antoine M Snijders; Daniel Pinkel; Stefan G M Meuwissen; Donna Albertson; Gerrit A Meijer
Journal:  Cell Oncol       Date:  2004       Impact factor: 6.730

10.  Single nucleotide polymorphisms in the metastasis-associated in colon cancer-1 gene predict the recurrence of hepatocellular carcinoma after transplantation.

Authors:  Zhiyun Zheng; Sheng Gao; Zhe Yang; Haiyang Xie; Cheng Zhang; Bingyi Lin; Liming Wu; Shusen Zheng; Lin Zhou
Journal:  Int J Med Sci       Date:  2014-01-05       Impact factor: 3.738

View more
  16 in total

Review 1.  In depth analysis of kinase cross screening data to identify chemical starting points for inhibition of the Nek family of kinases.

Authors:  C I Wells; N R Kapadia; R M Couñago; D H Drewry
Journal:  Medchemcomm       Date:  2017-12-08       Impact factor: 3.597

2.  Overexpression of NIMA-related kinase 2 is associated with poor prognoses in malignant glioma.

Authors:  Huajie Liu; Bin Liu; Xianzeng Hou; Bo Pang; Pengbo Guo; Wanli Jiang; Qian Ding; Rui Zhang; Tao Xin; Hua Guo; Shangchen Xu; Qi Pang
Journal:  J Neurooncol       Date:  2017-03-21       Impact factor: 4.130

Review 3.  The NEK family of serine/threonine kinases as a biomarker for cancer.

Authors:  Nagesh Kishan Panchal; Sabina Evan Prince
Journal:  Clin Exp Med       Date:  2022-01-17       Impact factor: 3.984

4.  Silencing of Nek2 suppresses the proliferation, migration and invasion and induces apoptosis of breast cancer cells by regulating ERK/MAPK signaling.

Authors:  Zeyu Xing; Menglu Zhang; Xin Wang; Jiaqi Liu; Gang Liu; Kexin Feng; Xiang Wang
Journal:  J Mol Histol       Date:  2021-05-19       Impact factor: 2.611

5.  Genome-scale analysis identifies NEK2, DLGAP5 and ECT2 as promising diagnostic and prognostic biomarkers in human lung cancer.

Authors:  Yuan-Xiang Shi; Ji-Ye Yin; Yao Shen; Wei Zhang; Hong-Hao Zhou; Zhao-Qian Liu
Journal:  Sci Rep       Date:  2017-08-14       Impact factor: 4.379

6.  Prognostic value of NEK2 overexpression in digestive system cancers: a meta-analysis and systematic review.

Authors:  Qian Ren; Bowen Li; Min Liu; Zenan Hu; Yuping Wang
Journal:  Onco Targets Ther       Date:  2018-10-18       Impact factor: 4.147

7.  MicroRNA-128 promotes apoptosis in lung cancer by directly targeting NIMA-related kinase 2.

Authors:  Dejian Zhao; Wenzheng Han; Xia Liu; Dawei Cui; Yu Chen
Journal:  Thorac Cancer       Date:  2017-05-17       Impact factor: 3.500

8.  Colon cancer-induced interleukin-35 inhibits beta-catenin-mediated pro-oncogenic activity.

Authors:  Yueqiang Jiang; Yanling Ma; RuiChao Li; JianHai Sun
Journal:  Oncotarget       Date:  2017-12-01

9.  Preoperative imaging markers and PDZ-binding kinase tissue expression predict low-risk disease in endometrial hyperplasias and low grade cancers.

Authors:  Ingfrid S Haldorsen; Camilla Krakstad; Anna Berg; Ankush Gulati; Sigmund Ytre-Hauge; Kristine E Fasmer; Karen K Mauland; Erling A Hoivik; Jenny A Husby; Ingvild L Tangen; Jone Trovik; Mari K Halle; Ingunn Stefansson; Lars A Akslen; Kathrine Woie; Line Bjørge; Helga B Salvesen; Øyvind O Salvesen; Henrica M J Werner
Journal:  Oncotarget       Date:  2017-07-31

Review 10.  Checking NEKs: Overcoming a Bottleneck in Human Diseases.

Authors:  Andressa Peres de Oliveira; Luidy Kazuo Issayama; Isadora Carolina Betim Pavan; Fernando Riback Silva; Talita Diniz Melo-Hanchuk; Fernando Moreira Simabuco; Jörg Kobarg
Journal:  Molecules       Date:  2020-04-13       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.